Pricing | |||||
5400 | |||||
3400 | |||||
1800 | |||||
Study Period | 2019-2030 |
Market Size (2023): | USD2Billion |
Market Size (2030): | USD4Billion |
CAGR (2023 - 2030): | 9.50% |
Fastest Growing Region | North America |
Dominating Region | Europe |
Report Features |
Details |
Base Year |
2023 |
Based Year Market Size (2023) |
USD2Billion |
Historical Period |
2019 to 2023 |
CAGR (2023 to 2030) |
9.50% |
Forecast Period |
2023 to 2030 |
Forecasted Period Market Size (2030) |
USD4Billion |
Scope of the Report |
Segmentation by Type Sublingual Vaccines, Injectable Vaccines, Segmentation by Application Immunotherapy, Prevention, Allergy Management, Clinical Trials, Sales Channel |
Regions Covered |
|
Companies Covered |
Aimmune Therapeutics, DBV Technologies, Allergy Therapeutics, Circassia, HAL Allergy, Aravax, ImmunoCap, Mylan, Pfizer |
Customization Scope |
15% Free Customization (For EG) |
Delivery Format |
PDF and Excel through Email |